当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 利润表

振东制药

(300158)

  

流通市值:59.06亿  总市值:60.54亿
流通股本:10.08亿   总股本:10.33亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312018-09-302018-06-30
一、营业总收入945,086,706.674,398,753,603.82,382,224,800.371,620,119,627.85
营业收入945,086,706.674,398,753,603.82,382,224,800.371,620,119,627.85
二、营业总成本870,687,953.024,229,909,944.522,315,668,016.271,524,116,036.28
营业成本374,606,740.261,548,909,497.37854,776,985.34584,900,568.87
营业税金及附加9,668,381.1644,687,429.2433,424,467.6221,484,486.07
销售费用384,812,221.652,173,077,063.321,175,436,009.07757,320,046.33
管理费用63,912,623.81295,591,473.46197,858,386.9152,674,398.82
财务费用2,742,199.0422,333,387.0117,047,391.0211,834,577.48
资产减值损失671,813.26-9,603,308.46-10,503,668.62-4,098,041.29
三、其他经营收益4,378.2236.79----
允许价值变动净收益-365.92-6,932.71-104,129.38-104,129.38
投资净收益2,832,235.86-15,606,816.114,272,764.713,335,392.33
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润73,515,038.96191,095,319.07107,509,896.91125,178,987.37
营业外收入1,010,933.932,999,010.734,293,215.07778,362.75
营业外支出6,376,841.062,670,392.058,043,887.425,528,508.61
非流动资产处置净损失--------
五、利润总额68,149,131.83191,423,937.75103,759,224.56120,428,841.51
所得税7,879,412.3754,386,705.3147,140,447.6232,598,589.48
未确认的投资损失--------
六、净利润(百万元)61.07142.76106.3651.45
少数股东损益-795,688.63-5,725,487.22-4,939,489.68-4,501,645.99
归属于母公司股东的净利润61,065,408.09142,762,719.6661,558,266.6292,331,898.02
七、每股收益0.060.14----
基本每股收益0.060.140.060.09
稀释每股收益0.060.140.060.09
TOP↑